BRIEF-Pluristem completes enrollment of 150 patients in phase II intermittent claudication trial

* Pluristem completes enrollment of 150 patients in phase ii

intermittent claudication trial

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom +91 80 6749-1130; within U.S. +1...

Read more